To provide antibodies, humanized antibodies, resurfaced antibodies, antibody fragments, derivatized antibodies, and conjugates of these with cytotoxic agents, which specifically bind to and inhibit insulin-like growth factor-I receptor, antagonize the effects of IGF-I, IGF-II, and serum on the growth and survival of tumor cells, and which are substantially devoid of agonist activity.
The antibodies and fragments thereof may be used in the treatment of tumors that express elevated levels of IGF-I receptor, such as breast cancer, colon cancer, lung cancer, ovarian carcinoma, synovial sarcoma, prostate cancer, and pancreatic cancer. The derivatized antibodies may be used in the diagnosis and imaging of tumors that express elevated levels of IGF-I receptor.
TAVARES DANIEL J
DAGDIGIAN NANCY E
JP2004531217A | 2004-10-14 | |||
JP2005536181A | 2005-12-02 | |||
JP2004531217A | 2004-10-14 | |||
JP2005536181A | 2005-12-02 |
JPN6009029223; 抗体工学入門 初版第1刷, 1994, 28-29, 株式会社地人書館
JPN6009029224; 抗体工学入門 初版第1刷, 1994, 230-231, 株式会社地人書館
JPN6009029225; Biochemical and Biophysical Research Communications Vol.171,No.3, 1990, p.1244-1251
JPN6009029223; 抗体工学入門 初版第1刷, 1994, 28-29, 株式会社地人書館
JPN6009029224; 抗体工学入門 初版第1刷, 1994, 230-231, 株式会社地人書館
Satoshi Fujita
Eiichi Arai
Natsuo Tanaka
Next Patent: DUMPLING PRODUCING DEVICE